Hi GW,
To be honest if I was just a punter I would wait till see if we get an approval. You will pay considerably more but the real money is after we get
the FDA nod with our other indications.
Its a bit different for some on here we have been following the story and
feel confident.
I just can not see Krause joining the Board , guiding the company thru the submission and then getting a negative decision.
Also is it possible Krause personally knows people that will look at the submission. Not sure if thats applicable but I wonder.
Aloha.
Ann: Biotech Showcase 2023 Presentation in San Francisco, page-165
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |